Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

  1. Pawlyn, C.
  2. Schjesvold, F.H.
  3. Cairns, D.A.
  4. Wei, L.J.
  5. Davies, F.
  6. Nadeem, O.
  7. Abdulhaq, H.
  8. Mateos, M.-V.
  9. Laubach, J.
  10. Weisel, K.
  11. Ludwig, H.
  12. Rajkumar, S.V.
  13. Sonneveld, P.
  14. Jackson, G.
  15. Morgan, G.
  16. Richardson, P.G.
Aldizkaria:
Blood Cancer Journal

ISSN: 2044-5385

Argitalpen urtea: 2024

Alea: 14

Zenbakia: 1

Mota: Berrikuspena

DOI: 10.1038/S41408-024-01109-4 GOOGLE SCHOLAR lock_openSarbide irekia editor